| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2380000A1 Odorant receptors |
| 01/25/2001 | CA2379983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | CA2379968A1 Gtp-binding protein associated factors |
| 01/25/2001 | CA2379925A1 Polypeptides and polynucleotides encoding same |
| 01/25/2001 | CA2379857A1 Mites-like element and transcriptional activation element |
| 01/25/2001 | CA2379852A1 Method for down-regulating gdf-8 activity |
| 01/25/2001 | CA2379850A1 Environmental stress tolerant gene |
| 01/25/2001 | CA2379849A1 Process for the preparation of l-amino acids from their racemic n-acetyl-d,l derivatives by enzymatic resolution by means of isolated, recombinant enzymes |
| 01/25/2001 | CA2379825A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 01/25/2001 | CA2379749A1 Multiplexed strand displacement for nucleic acid determinations |
| 01/25/2001 | CA2379700A1 Maize orthologues of bacterial ruvb:cdnas and uses thereof |
| 01/25/2001 | CA2379693A1 Amplification of nucleic acids with electronic detection |
| 01/25/2001 | CA2379683A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 01/25/2001 | CA2379627A1 Inhibitor proteins |
| 01/25/2001 | CA2379618A1 Viral protein binding compositions and methods |
| 01/25/2001 | CA2379580A1 Novel human calcium sensitive potassium channel subunits |
| 01/25/2001 | CA2379391A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | CA2379349A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | CA2379336A1 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | CA2379212A1 Methods for determining the specificity and sensitivity of oligonucleotides for hybridization |
| 01/25/2001 | CA2379143A1 In vitro selection and optional identification of polypeptides using solid support carriers |
| 01/25/2001 | CA2379129A1 Fima pilus-based vaccines |
| 01/25/2001 | CA2379076A1 Transformation method and transgenic plants produced thereby |
| 01/25/2001 | CA2379069A1 Fimh adhesin-based vaccines |
| 01/25/2001 | CA2379055A1 Trap vectors and gene trapping using the same |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378933A1 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378249A1 Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 01/25/2001 | CA2378070A1 A method for amplifying low abundance nucleic acid sequences and means for performing said method |
| 01/25/2001 | CA2378061A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377937A1 Oligoneucleotides for metabotropic glutamate receptor type 1 (mglur1) |
| 01/25/2001 | CA2377906A1 Methods for producing and preparing cells for cell therapy |
| 01/25/2001 | CA2376641A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | CA2376518A1 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | CA2375943A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 01/25/2001 | CA2375467A1 Antisense therapy for hormone-regulated tumors |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2373690A1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 01/25/2001 | CA2343970A1 Process for producing optically active pyridineethanol derivatives |
| 01/25/2001 | CA2343728A1 Assay member and method for its manufacture |
| 01/25/2001 | CA2340721A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/24/2001 | EP1070962A2 Method for detecting low density lipoprotein (LDL) or denatured low density lipoprotein in blood |
| 01/24/2001 | EP1070759A1 Process for producing coenzyme q10 |
| 01/24/2001 | EP1070758A1 Novel protein and processes for producing the same |
| 01/24/2001 | EP1070454A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor |
| 01/24/2001 | EP1070257A2 Directed evolution biosensors |
| 01/24/2001 | EP1070255A1 Assay of igfbp complex |
| 01/24/2001 | EP1070254A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions |
| 01/24/2001 | EP1070246A1 Method for electroelution of a biological sample and implementing device |
| 01/24/2001 | EP1070145A1 Methods for identifying genetic determinants associated with modulation of test compound activity |
| 01/24/2001 | EP1070143A2 Glaucoma therapeutics and diagnostics |
| 01/24/2001 | EP1070142A1 Method for using a quality metric to assess the quality of biochemical separations |
| 01/24/2001 | EP1070141A1 Immediate early genes and methods of use therefor |
| 01/24/2001 | EP1070140A1 Compositions and methods for treating cells having double minute dna |
| 01/24/2001 | EP1070134A2 Growth differentiation factor-9 regulatory sequences and uses therefor |
| 01/24/2001 | EP1070133A2 Biological material with increased expression of endogenous complement regulatory molecules |
| 01/24/2001 | EP1070132A2 RECOMBINANT L-N-CARBAMOYLASE DERIVED FROM $i(ARTHROBACTER AURESCENS), AND A METHOD FOR PRODUCING L-AMINO ACIDS BY USING THE SAME |
| 01/24/2001 | EP1070130A2 Sucrose transporters from plants |
| 01/24/2001 | EP1070129A2 Dadd, death activator death domain protein |
| 01/24/2001 | EP1070128A1 Axor4 g-protein-coupled receptor |
| 01/24/2001 | EP1070127A1 DNA SEQUENCE IN THE Sp5 MUTANT AND SITE SPECIFIC GENETIC RECOMBINATION |
| 01/24/2001 | EP1070126A1 Epitope-driven human antibody production and gene expression profiling |
| 01/24/2001 | EP1070125A2 Human nucleic acid sequences from normal breast tissue |
| 01/24/2001 | EP1070123A2 Herpes simplex virus latency associated transcript polypeptides |
| 01/24/2001 | EP1070122A2 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 01/24/2001 | EP1070121A1 The cytokine family member ef-7 |
| 01/24/2001 | EP1070120A1 Amp deaminase |
| 01/24/2001 | EP1070118A1 Modified adenovirus containing a fiber replacement protein |
| 01/24/2001 | EP1070117A1 Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase |
| 01/24/2001 | EP1070081A1 Novel molecules of the t129-related protein family and uses thereof |
| 01/24/2001 | EP1070080A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 01/24/2001 | EP1069917A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
| 01/24/2001 | EP1069909A2 Conjugate vaccines for the prevention of dental caries |
| 01/24/2001 | EP1069908A2 Methods and modified cells for the treatment of cancer |
| 01/24/2001 | EP1069821A1 Method of controlling proliferation and differentiation of stem and progenitor cells |
| 01/24/2001 | EP0904392B1 Retroviral vectors |
| 01/24/2001 | EP0820471B1 Antibodies against heart muscle actin |
| 01/24/2001 | EP0543942B1 Homogeneous assay system |
| 01/24/2001 | CN1281512A Selective killing and diagnosis of P53+ neoplastic cells |
| 01/24/2001 | CN1281511A Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same |
| 01/24/2001 | CN1281510A Method for increasing hemoprotein production in fungal mutants |
| 01/24/2001 | CN1281509A Human MDG1 gene (CBFAWB10) |
| 01/24/2001 | CN1281508A Human Sel-10 polypeptides and polynucleotides that encode them |
| 01/24/2001 | CN1281468A Treatment with anti-ErbB2 antibodies |
| 01/24/2001 | CN1281465A Human FK 506 binding protein (FKBP) |
| 01/24/2001 | CN1281464A Human PTD 011 gene (TPAAHE09) |
| 01/24/2001 | CN1281463A Human PTD 010 gene (TPAAAG12) |
| 01/24/2001 | CN1281462A Isolation of nucleic acids |
| 01/24/2001 | CN1281371A Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| 01/24/2001 | CN1281367A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 01/24/2001 | CN1281366A Prevention and treatment of amyloidogenic disease |
| 01/24/2001 | CN1281355A Biodegradable mixed polymeric micelles for gene delivery |
| 01/24/2001 | CN1281336A Treatment of neoplasms with viruses |
| 01/24/2001 | CN1281049A Hay bacillus expression element of giant bacillus penicillin G amidase |
| 01/24/2001 | CN1281048A Reconstituted human t-PA molecule and its engineering bacterium strain to express it |
| 01/24/2001 | CN1281047A Human limb deformation protein and its coding sequence |